PCV74 COST-EFFECTIVENESS OF RIVAROXABAN 2.5 MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
HomePublicationsPCV74 COST-EFFECTIVENESS OF RIVAROXABAN 2.5 MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
PCV74 COST-EFFECTIVENESS OF RIVAROXABAN 2.5 MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
2019 Value in Health
Kalogeropoulou, M. | Gkouvitsos, I. | Barlogiannis, T. | Bowrin, K. | Briere, J.B. | Millier, A. | Karabis, A. |
Volume: 22,
Issue: ,
Pages: S555,
